
Loading, please wait...

Loading, please wait...

The recent Max Healthcare acquisition of a 58.4 per cent stake in Kalinga Hospital marks a significant milestone for the healthcare chain. Valued at ₹300 crore, this transaction represents the group\'s first venture into the Odisha market. Consequently, the deal strengthens its footprint in Eastern India, a region seeing rapid healthcare demand growth. This 250-bed NABH-accredited facility serves as a robust platform for further brownfield developments.
Kalinga Hospital operates from a prime 10-acre land parcel in Bhubaneswar. Specifically, it provides comprehensive services across Neurology, Cardiology, and Orthopaedics. The hospital also excels in Gastroenterology, Renal Sciences, and Oncology. Furthermore, the facility houses an advanced in-house diagnostics unit. This unit includes a 128-slice CT scanner, a 1.5T MRI, and a modern Cath Lab. Therefore, patients in the region gain access to high-end medical technology under a reputable corporate brand.
Max Healthcare continues to target non-metro markets for scaling operations. Notably, the company surpassed the ₹1 lakh crore market capitalisation mark last year. This financial strength allows it to pursue both greenfield and brownfield opportunities aggressively. For instance, the chain recently signed a deal to develop a 450-bed hospital in Pune. Chairman Abhay Soi emphasized that the Bhubaneswar market offers significant operational upside. Consequently, the company plans to utilize the site\'s capacity for substantial long-term expansion.
Q1: What is the current bed capacity of Kalinga Hospital?
Kalinga Hospital is a 250-bed NABH-accredited multispecialty facility located in Bhubaneswar, Odisha.
Q2: How much did Max Healthcare pay for the controlling stake?
Max Healthcare acquired a 58.4 per cent stake in Kalinga Hospital for an equity value of ₹300 crore.
Q3: What specialties are offered at Kalinga Hospital?
The hospital provides services in Cardiology, Oncology, Neurology, Gastroenterology, Orthopaedics, and Renal Sciences.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Max Healthcare acquires 58.4% of Kalinga Hospital in Bhubaneswar for ₹300 crore, marking its entry into Odisha with a 250-bed facility and expansion plans....
5 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today